Buscar en
Endocrinología, Diabetes y Nutrición
Toda la web
XXX Congreso Nacional de la Sociedad Española de Diabetes EXPERIMENTAL, GENÉTICA Y OTROS
Información de la revista

Congreso

Contenidos del congreso
Congreso
XXX Congreso Nacional de la Sociedad Española de Diabetes
Sevilla, 24-26 Abril 2019
Listado de sesiones
Comunicación
14. EXPERIMENTAL, GENÉTICA Y OTROS
Texto completo

P-123 - VITAMIN B3 IMPAIRS CHOLESTEROL METABOLISM IN HYPERCHOLESTEROLEMIC MICE

K.A. Méndez Laraa, D. Santosb, N. Farréc, M.N. Nand, A. Pérez-Pérezc, F. Blanco-Vacac and J. Julvee

aInstitut de Recerca Hospital de la Santa Creu i Sant Pau, Barcelona. bCIBER de Diabetes y Enfermedades Metabólicas Asociadas, CIBERDEM, Barcelona. cCIBER de Diabetes y Enfermedades Metabólicas Asociadas, CIBERDEM. Hospital de la Santa Creu i Sant Pau, Barcelona. dHospital de la Santa Creu i Sant Pau, Barcelona. eInstitut de Recerca de l’Hospital de la Santa Creu i Sant Pau i Institut d’Investigació Biomèdica de l'Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau. CIBER de Diabetes y Enfermedades Metabólicas Asociadas, CIBERDEM, Barcelona.

Objectives: To study the effect of vitamin B3 administration over HDL function in a mouse model of hypercholesterolemia.

Methods: Apolipoprotein E-deficient (KOE) mice were challenged with a high-fat diet for 4 weeks. Groups of five KOE mice were treated with different doses of vitamin B3 (i.e., 0.25% and 1%) via tap water.

Results: The administration of vitamin B3 to KOE mice produced an elevation (∼1.5-fold; p < 0.05) in the plasma levels of cholesterol, which was mainly accounted for the non-HDL fraction. Compared with untreated mice, the administration of vitamin B3 to KOE mice produced a [3H]-cholesterol plasma accumulation (∼1.5-fold; p < 0.05) in the m-RCT. As revealed by kinetic analysis, the latter was mainly explained by an impaired clearance of non-HDL lipoproteins (∼0.8-fold; p < 0.05) in high-dose, vitamin B3-treated KOE mice. Consistently, the relative content of [3H]-tracer was lowered in the livers (∼0.6-fold; p < 0.05) and feces (> 0.5-fold; p < 0.05) of vitamin B3-treated mice. Nevertherless, the relative gene expression of several targets controlling hepatobiliary removal of cholesterol to feces, which include Abcg5 and Abcg8, showed a trend to be or were up-regulated in the liver (Abcg5: 2.9-fold; p < 0.05; Abcg8: 2.4-fold; p = 0.06) and small intestine (Abcg5: 2.1-fold; p = 0.15; Abcg8: 1.9-fold; p < 0.05) of high-dose, vitamin B3-treated mice.

Conclusions: Our data show that the administration of vitamin B3 to KOE mice impaired m-RCT in vivo. This finding was in part due to a defective clearance and reduced hepatic uptake of plasma non-HDL lipoproteins.

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.